Maternal

Cuts to family planning aid are linked to an 11% increase in deaths during pregnancy and childbirth in some countriesWhen Republican presidents win power in the US there is a stark consequence for many pregnant woman around the world – a significant rise in maternal mortality as aid is withdrawn, a new study has found.Global family planning aid typically drops under Republican presidents and then rises again by 48% once Democratic presidents are elected, the research, published in BMJ Global Health, finds. Continue reading...

• The FDA approved the first RSV vaccine for infants via maternal immunization on March 18, 2026, allowing pregnant women to receive vaccination in the third trimester to confer passive immunity to newborns. • The approval is based on a Phase 3 trial showing 82% efficacy in preventing severe RSV disease in infants under six months, with passive immunity lasting approximately three months post-birth. • RSV causes approximately 100,000 hospitalizations and 300-400 deaths annually among US infants, making this vaccine potentially transformative for preventing severe respiratory illness in the most vulnerable population.

• Heartland Forward-commissioned research released March 19 reveals broad U.S. consensus on maternal health priorities and actionable steps forward. • Conducted in Bentonville, Ark., the poll finds Americans ready to address maternal care gaps nationwide. • Results point to unified public support for policy and community interventions to boost outcomes.